199 related articles for article (PubMed ID: 4145870)
21. Effects of 2-and/or 5-methylated analogues of 6-hydroxydopamine on norepinephrine-and dopamine-containing neurons.
Liang YO; Adams RN
Mol Pharmacol; 1977 Sep; 13(5):805-18. PubMed ID: 895717
[No Abstract] [Full Text] [Related]
22. Sulfanilic acid: behavioral change related to azo food dyes in developing rats.
Goldenring JR; Batter DK; Shaywitz BA
Neurobehav Toxicol Teratol; 1982; 4(1):43-9. PubMed ID: 6803178
[TBL] [Abstract][Full Text] [Related]
23. Effect of central catecholamine depletions by 6-hydroxydopamine on morphine antinociception in rats.
Elchisak MA; Rosecrans JA
Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):349-52. PubMed ID: 4734013
[No Abstract] [Full Text] [Related]
24. Effects of amphetamine on electroshock responses in developing rats.
Vernadakis A; Robb D
Dev Psychobiol; 1974 Jan; 7(1):89-95. PubMed ID: 4812273
[No Abstract] [Full Text] [Related]
25. Environmental and biologic interactions on behavior: effects of artificial rearing in rat pups treated with 6-hydroxydopamine.
Goldenring JR; Shaywitz BA; Wool RS; Batter DK; Anderson GM; Cohen DJ
Dev Psychobiol; 1982 Jul; 15(4):297-307. PubMed ID: 6809512
[No Abstract] [Full Text] [Related]
26. Changes in hyporesponsiveness to acute amphetamine and age differences in tyrosine hydroxylase immunoreactivity in the brain over adolescence in male and female rats.
Mathews IZ; Waters P; McCormick CM
Dev Psychobiol; 2009 Jul; 51(5):417-28. PubMed ID: 19492363
[TBL] [Abstract][Full Text] [Related]
27. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats.
Criswell HE; Johnson KB; Mueller RA; Breese GR
J Pharmacol Exp Ther; 1993 May; 265(2):1001-10. PubMed ID: 8098756
[TBL] [Abstract][Full Text] [Related]
28. In vivo studies on central noradrenergic synaptic mechanisms after acute and chronic antidepressant drug treatment: biochemical and behavioral comparison.
Racagni G; Mocchetti I; Renna G; Cuomo V
J Pharmacol Exp Ther; 1982 Oct; 223(1):227-34. PubMed ID: 7120121
[No Abstract] [Full Text] [Related]
29. The aggressive monoamines.
Eichelman BS; Thoa NB
Biol Psychiatry; 1973 Apr; 6(2):143-64. PubMed ID: 4736194
[No Abstract] [Full Text] [Related]
30. Temporal changes in amine synthesizing enzymes of rat extrapyramidal structures after hemitransections or 6-hydroxydopamine administration.
McGeer EG; Fibiger HC; McGeer PL; Brooke S
Brain Res; 1973 Mar; 52():289-300. PubMed ID: 4144770
[No Abstract] [Full Text] [Related]
31. Some aspects of the behavior of young and adult rats treated with p-chlorophenylalanine in infancy.
Adlard BP; Smart JL
Dev Psychobiol; 1974 Mar; 7(2):135-44. PubMed ID: 4362763
[No Abstract] [Full Text] [Related]
32. Selective depletion of dopamine following O-methylation of 6-hydroxydopamine.
Ho BT; Meyer AL; Taylor D
Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):47-56. PubMed ID: 4734016
[No Abstract] [Full Text] [Related]
33. Neonatal sympathectomy by 6-hydroxydopamine in the rat: no effects on behavior by changes in endogenous brain norepinephrine.
Pappas BA; Sobrian SK
Life Sci I; 1972 Jul; 11(14):653-9. PubMed ID: 4656097
[No Abstract] [Full Text] [Related]
34. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
Robbins TW; Roberts DC; Koob GF
J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
[TBL] [Abstract][Full Text] [Related]
35. Behavioral effects of alpha-methyltyrosine after prior depletion of brain catecholamines.
Rech RH; Carr LA; Moore KE
J Pharmacol Exp Ther; 1968 Apr; 160(2):326-35. PubMed ID: 5651375
[No Abstract] [Full Text] [Related]
36. Effects of chronic administration of food colorings on activity levels and cognitive performance in developing rat pups treated with 6-hydroxydopamine.
Shaywitz BA; Goldenring JR; Wool RS
Neurobehav Toxicol; 1979; 1(1):41-7. PubMed ID: 551301
[No Abstract] [Full Text] [Related]
37. Methadone exposure in utero: effects on brain biogenic amines and behavior.
Rech RH; Lomuscio G; Algeri S
Neurobehav Toxicol; 1980; 2(2):75-8. PubMed ID: 7197331
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the behavioral depressant effects of biogenic amine depleting and neuroleptic agents following various 6-hydroxydopamine treatments.
Cooper BR; Grant LD; Breese GR
Psychopharmacologia; 1973 Jul; 31(2):95-109. PubMed ID: 4722209
[No Abstract] [Full Text] [Related]
39. Deficits in instrumental responding after 6-hydroxydopamine lesions of the nigro-neostriatal dopaminergic projection.
Fibiger HC; Phillips AG; Zis AP
Pharmacol Biochem Behav; 1974; 2(1):87-96. PubMed ID: 4151316
[No Abstract] [Full Text] [Related]
40. Behavior and brain growth in rats treated with p-chlorophenylalanine in the first weeks of life.
Hole K
Dev Psychobiol; 1972; 5(2):157-73. PubMed ID: 4276421
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
